Cytodyme, Inc.
AI-Enabled Quality and Regulatory Workflows
Funding history
About Cytodyme, Inc.
How much funding has Cytodyme, Inc. raised?
Cytodyme, Inc. has raised $75K in total funding. The most recent round was Seed.
Where is Cytodyme, Inc. headquartered?
Cytodyme, Inc. is headquartered in San Diego, CA.
What does Cytodyme, Inc. do?
AI-Enabled Quality and Regulatory Workflows
What problem does Cytodyme, Inc. solve?
Medtech quality and regulatory teams struggle with repetitive reporting and disconnected files when managing complaints, investigations, vigilance, and post-market (MDR/IVDR) reporting.
What's Cytodyme, Inc.'s solution?
Cytodyme is an AI-powered platform that centralizes complaint management, literature surveillance, and a lean QMS, and automatically generates audit-ready post-market reports (PSUR, PMPF, CER) from connected, traceable data.
What makes Cytodyme, Inc. different?
The platform is FDA 21 CFR Part 11 compliant with end-to-end audit trails, automatically groups similar complaints even when worded differently, and updates risk/severity assessments as new facts emerge.
What makes Cytodyme, Inc. notable?
Cytodyme is a Techstars portfolio company (Techstars '25) co-founded by Dennis "D.J." White and Tammy Ogden, both MBA students at UC San Diego's Rady School of Management.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.